Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (371-380 of 479) with videos related to

Pageof 48
Sort By:
Nature Communications|July 8, 2025
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndromeZhenhua Li, Wenjian Yang, Gang Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
JAK mutations in high-risk childhood acute lymphoblastic leukemiaCharles G Mullighan, Jinghui Zhang, Richard C Harvey, et al.
Leukemia|March 25, 2023
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Leukemia|May 8, 2023
Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Nature Communications|April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemiaJuwita Werner, Alex G Lee, Chujing Zhang, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Pageof 48

Showing results (371-380 of 479) with videos related to

Sort By:
Pageof 48
Nature Communications|July 8, 2025
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndromeZhenhua Li, Wenjian Yang, Gang Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331Kelly W Maloney, Meenakshi Devidas, Cindy Wang, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
JAK mutations in high-risk childhood acute lymphoblastic leukemiaCharles G Mullighan, Jinghui Zhang, Richard C Harvey, et al.
Leukemia|March 25, 2023
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Leukemia|May 8, 2023
Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Nature Communications|April 23, 2025
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemiaJuwita Werner, Alex G Lee, Chujing Zhang, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Pageof 48